NASDAQ:ARTL - Artelo Biosciences Stock Price, News, & Analysis

$3.21
-0.18 (-5.31 %)
(As of 07/17/2019 04:00 PM ET)
Today's Range
$3.10
Now: $3.21
$3.65
50-Day Range N/A
52-Week Range
$1.62
Now: $3.21
$10.50
Volume1,733 shs
Average Volume59,419 shs
Market Capitalization$10.95 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Artelo Biosciences, Inc., an ethical biopharmaceutical company, focuses on developing, licensing, and commercializing cannabinoid therapeutic treatments. Its products pipeline includes ART12.11, a cannabidiol composition for the treatment of inflammatory bowel disease, stroke, and rare/orphan diseases; ART26.12, an endocannabinoid transport protein (FABP5) inhibitor for the treatment of breast cancer, prostate cancer, and neuropathic and nociceptive pain; and ART27.13 for the treatment of cancer and cachexia. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was founded in 2011 and is based in La Jolla, California.

Industry, Sector and Symbol

Industry Business services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:ARTL
CUSIPN/A
CIKN/A
Phone760-943-1689

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees1
Market Cap$10.95 million
Next Earnings Date10/21/2019 (Estimated)
OptionableNot Optionable

Receive ARTL News and Ratings via Email

Sign-up to receive the latest news and ratings for ARTL and its competitors with MarketBeat's FREE daily newsletter.

Artelo Biosciences (NASDAQ:ARTL) Frequently Asked Questions

What is Artelo Biosciences' stock symbol?

Artelo Biosciences trades on the NASDAQ under the ticker symbol "ARTL."

When is Artelo Biosciences' next earnings date?

Artelo Biosciences is scheduled to release their next quarterly earnings announcement on Monday, October 21st 2019. View Earnings Estimates for Artelo Biosciences.

What price target have analysts set for ARTL?

1 equities research analysts have issued 12-month price targets for Artelo Biosciences' shares. Their forecasts range from $8.00 to $8.00. On average, they expect Artelo Biosciences' stock price to reach $8.00 in the next twelve months. This suggests a possible upside of 149.2% from the stock's current price. View Analyst Price Targets for Artelo Biosciences.

What is the consensus analysts' recommendation for Artelo Biosciences?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Artelo Biosciences in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Artelo Biosciences.

Has Artelo Biosciences been receiving favorable news coverage?

News headlines about ARTL stock have been trending somewhat positive on Wednesday, according to InfoTrie Sentiment. The research group identifies negative and positive news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Artelo Biosciences earned a daily sentiment score of 1.4 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for Artelo Biosciences.

Who are some of Artelo Biosciences' key competitors?

What other stocks do shareholders of Artelo Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Artelo Biosciences investors own include Chemesis International (CADMF), Waste Management (WM), istar (STAR), Nokia Oyj (NOK) and Forrester Research (FORR).

Who are Artelo Biosciences' key executives?

Artelo Biosciences' management team includes the folowing people:
  • Mr. Gregory D. Gorgas, Pres, CEO, CFO, Treasurer, Sec. & Director (Age 56)
  • Mr. Peter Michael O'Brien, Sr. VP of European Operations (Age 41)
  • Dr. Steven D. Reich, Chief Medical Officer (Age 73)
  • Mr. Jason H. Baybutt, Sr. VP of Fin. (Age 47)

How do I buy shares of Artelo Biosciences?

Shares of ARTL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Artelo Biosciences' stock price today?

One share of ARTL stock can currently be purchased for approximately $3.21.

How big of a company is Artelo Biosciences?

Artelo Biosciences has a market capitalization of $10.95 million. Artelo Biosciences employs 1 workers across the globe.View Additional Information About Artelo Biosciences.

What is Artelo Biosciences' official website?

The official website for Artelo Biosciences is http://www.artelobio.com/.

How can I contact Artelo Biosciences?

Artelo Biosciences' mailing address is 888 PROSPECT STREET SUITE 210, LA JOLLA CA, 92037. The company can be reached via phone at 760-943-1689 or via email at [email protected]


MarketBeat Community Rating for Artelo Biosciences (NASDAQ ARTL)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  6 (Vote Outperform)
Underperform Votes:  5 (Vote Underperform)
Total Votes:  11
MarketBeat's community ratings are surveys of what our community members think about Artelo Biosciences and other stocks. Vote "Outperform" if you believe ARTL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ARTL will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel